Skip to main content
SpringerPlus

Table 1 Demographics of the patients

From: Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study

 

PLT group (n = 295)

SLT group (n = 76)

P value

Age, years

48.3 ± 8.5

48.5 ± 8.6

0.870

Gender (male/female)

263/32

68/8

0.936

Blood type (A/B/AB/O)

95/82/38/80

32/16/10/18

0.385

Preoperative MELD score

11.0 ± 4.4

10.6 ± 5.8

0.570

AFP >400 ng/mL, no (%)

101 (34.2)

14 (18.4)

0.008

Underlying liver disease, no (%)

 HBV

277 (93.9)

68 (89.5)

 

 HCV

2 (0.7)

2 (2.6)

 

 Autoimmune hepatitis

11 (3.7)

4(5.3)

 

 Wilson’s disease

1 (0.3)

0 (0)

 

 Chronic alcoholism

2 (0.7)

0 (0)

 

 Cryptogenic

2 (0.7)

2 (2.6)

0.272

Child–Pugh grading (A/B/C)

150/109/36

56/14/6

0.002

  1. PLT primary liver transplantation, SLT salvage liver transplantation, MELD model for end-stage liver disease, AFP alpha-fetoprotein, HBV hepatitis B virus, HCV, hepatitis C virus, HCC hepatocellular carcinoma
Back to article page